Has Karl Tucker received payments from drug or device companies?

Yes. Drug and device makers reported $2,944 in general payments to Karl Tucker across 141 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Karl Tucker did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Karl Tucker come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Karl Tucker

Psychiatric/Mental Health · Orem, UTNPI 1932693587

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $889 and has fallen 51.9% since, to $428 in 2025.

$2,944in general payments, 2019–2025

Across 141 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$550
Teva Pharmaceuticals USA, Inc.$542
AbbVie$441
Otsuka America Pharmaceutical, Inc.$326
Alkermes, Inc.$186
Neurocrine Biosciences, Inc.$172
plus $727 from 12 others

What the payments were for

Food & beverage$2,944100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	18	$550
Teva Pharmaceuticals USA, Inc.	33	$542
AbbVie(2 entities)	24	$441
Otsuka America Pharmaceutical, Inc.	16	$326
Alkermes, Inc.	9	$186
Neurocrine Biosciences, Inc.	7	$172
Lundbeck LLC	8	$133
Vanda Pharmaceuticals Inc.	5	$133
E.r. Squibb & Sons, L.L.C.	2	$126
Takeda Pharmaceuticals U.S.A., Inc.	6	$112
Sunovion Pharmaceuticals Inc.	3	$45
Braeburn Inc.	2	$36
Merck	1	$34
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$31
Pfizer	2	$28
Idorsia Pharmaceuticals US Inc	1	$19
Axsome Therapeutics, Inc.	1	$16
Bausch Health US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,944 in reported general payments places this provider in the 85th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah →

Other psychiatric/mental health in Orem

Anthony BrowningOrem$32K
Lisa OlsenOrem$5K
Deven JenningsOrem$3K
Bret HafenLayton$381K
Alberto SouzaSaint George$114K
Debra HainRiverton$29K
Kristin BarberSalt Lake City$28K
Briana TerrySalt Lake City$14K
Paige MarshallSaint George$13K
Derick MoodySpringville$8K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →